Walsh & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Walsh & Associates's PFE Position: Q3 2026 in Review
Walsh & Associates opened a new position in Pfizer (PFE) in Q3 2026: 150 shares worth $4.28K. The stake represents ﹤0.01% of the portfolio and ranks #226 among its holdings. This is a return to the name: Walsh & Associates previously reported a position in PFE as recently as Q1 2026.
Walsh & Associates first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Walsh & Associates held 150 shares of Pfizer worth $4.28K as of Q3 2026.
- Pfizer was a new Walsh & Associates position in Q3 2026.
- Pfizer made up ﹤0.01% of Walsh & Associates's portfolio in Q3 2026, its #226 holding.
- Walsh & Associates first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
- 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.